CH566344A5 - - Google Patents

Info

Publication number
CH566344A5
CH566344A5 CH316071A CH316071A CH566344A5 CH 566344 A5 CH566344 A5 CH 566344A5 CH 316071 A CH316071 A CH 316071A CH 316071 A CH316071 A CH 316071A CH 566344 A5 CH566344 A5 CH 566344A5
Authority
CH
Switzerland
Application number
CH316071A
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH566344A5 publication Critical patent/CH566344A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH316071A 1970-03-05 1971-03-04 CH566344A5 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1695770A 1970-03-05 1970-03-05
US14934271A 1971-06-02 1971-06-02

Publications (1)

Publication Number Publication Date
CH566344A5 true CH566344A5 (cg-RX-API-DMAC10.html) 1975-09-15

Family

ID=26689269

Family Applications (1)

Application Number Title Priority Date Filing Date
CH316071A CH566344A5 (cg-RX-API-DMAC10.html) 1970-03-05 1971-03-04

Country Status (9)

Country Link
US (2) US3646049A (cg-RX-API-DMAC10.html)
AT (1) AT310738B (cg-RX-API-DMAC10.html)
BE (1) BE763781R (cg-RX-API-DMAC10.html)
CA (1) CA967962A (cg-RX-API-DMAC10.html)
CH (1) CH566344A5 (cg-RX-API-DMAC10.html)
DE (1) DE2110396A1 (cg-RX-API-DMAC10.html)
FR (1) FR2085671B1 (cg-RX-API-DMAC10.html)
GB (2) GB1317379A (cg-RX-API-DMAC10.html)
NL (2) NL7102895A (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1221596A (en) * 1967-12-06 1971-02-03 Merck & Co Inc Benzimidazole derivatives
US3922262A (en) * 1971-04-28 1975-11-25 Nippon Kayaku Kk N-Substituted derivatives of bleomycins
US3956488A (en) * 1973-09-27 1976-05-11 Merck & Co., Inc. Compositions and methods for the treatment of helminthiasis
US4405621A (en) * 1974-02-07 1983-09-20 Smith Kline & French Laboratories Limited Heterocyclic thioureas, isothioureas, guanidines and nitromethylene-amidines
GB1493931A (en) * 1974-02-07 1977-11-30 Smith Kline French Lab Guanidines isothioureas and thioureas
US4649149A (en) * 1980-05-22 1987-03-10 Ciba-Geigy Corporation Process for the manufacture of novel benzazole derivatives, pharmaceutical preparations containing these derivatives, and their use
MA19290A1 (fr) * 1980-05-22 1982-04-01 Ciba Geigy Ag Derives du benzole,leur preparaton et leur utilisations therapeutiques .
US5247085A (en) * 1987-11-30 1993-09-21 Beecham Group P.L.C. Antiviral purine compounds
EP0319228B1 (en) * 1987-11-30 1994-11-02 Beecham Group Plc Novel compounds
US6255091B1 (en) 1995-04-28 2001-07-03 Axys Pharmaceuticals, Inc. Potentiating metal mediated serine protease inhibitors with cobalt or zinc ions
US5693515A (en) * 1995-04-28 1997-12-02 Arris Pharmaceutical Corporation Metal complexed serine protease inhibitors
EP1194152A4 (en) 1999-06-30 2002-11-06 Merck & Co Inc Links to SRC kinase inhibition
AU6605200A (en) 1999-06-30 2001-01-31 Merck & Co., Inc. Src kinase inhibitor compounds
WO2001000213A1 (en) 1999-06-30 2001-01-04 Merck & Co., Inc. Src kinase inhibitor compounds
US7405235B2 (en) * 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
US7622592B2 (en) * 2002-11-01 2009-11-24 Merck & Co., Inc. Carbonylamino-benzimidazole derivatives as androgen receptor modulators
EP1558341A4 (en) * 2002-11-01 2010-09-08 Paratek Pharm Innc TRANSCRIPTION FACTOR MODULATING CONNECTIONS AND THEIR USE
WO2006076009A2 (en) 2004-04-23 2006-07-20 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
US20090170812A1 (en) * 2006-06-23 2009-07-02 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
WO2009005551A2 (en) * 2007-03-27 2009-01-08 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
US20090191138A1 (en) * 2008-01-30 2009-07-30 Mediquest Therapeutics, Inc. Novel topical formulations for improving the appearance of nails
CA2714370C (en) 2008-02-07 2017-05-02 Massachusetts Eye & Ear Infirmary Compounds that enhance atoh-1 expression
US20110059962A1 (en) * 2009-04-22 2011-03-10 Alekshun Michael N Transcription factor modulating compounds and methods of use thereof
US20230331705A1 (en) * 2020-05-20 2023-10-19 Senda Biosciences, Inc. Fused Imidazole Derivatives as AHR Antagonists

Also Published As

Publication number Publication date
FR2085671B1 (cg-RX-API-DMAC10.html) 1975-04-18
AT310738B (de) 1973-10-10
US3646049A (en) 1972-02-29
NL7102895A (cg-RX-API-DMAC10.html) 1971-09-07
BE763781R (fr) 1971-09-06
NL7102896A (cg-RX-API-DMAC10.html) 1971-09-07
GB1317379A (en) 1973-05-16
DE2110396A1 (de) 1971-09-23
CA967962A (en) 1975-05-20
GB1328321A (en) 1973-08-30
US3743738A (en) 1973-07-03
FR2085671A1 (cg-RX-API-DMAC10.html) 1971-12-31

Similar Documents

Publication Publication Date Title
ATA96471A (cg-RX-API-DMAC10.html)
AU1146470A (cg-RX-API-DMAC10.html)
AU2044470A (cg-RX-API-DMAC10.html)
AU1473870A (cg-RX-API-DMAC10.html)
AU1326870A (cg-RX-API-DMAC10.html)
AU1833270A (cg-RX-API-DMAC10.html)
AU2130570A (cg-RX-API-DMAC10.html)
AU2017870A (cg-RX-API-DMAC10.html)
AU1716970A (cg-RX-API-DMAC10.html)
AU1517670A (cg-RX-API-DMAC10.html)
AU1336970A (cg-RX-API-DMAC10.html)
AR195465A1 (cg-RX-API-DMAC10.html)
AU1591370A (cg-RX-API-DMAC10.html)
AU1083170A (cg-RX-API-DMAC10.html)
AU2144270A (cg-RX-API-DMAC10.html)
AU2131570A (cg-RX-API-DMAC10.html)
AU1277070A (cg-RX-API-DMAC10.html)
AU1328670A (cg-RX-API-DMAC10.html)
AU1247570A (cg-RX-API-DMAC10.html)
AU1343870A (cg-RX-API-DMAC10.html)
AU1235770A (cg-RX-API-DMAC10.html)
AU2130770A (cg-RX-API-DMAC10.html)
AU1004470A (cg-RX-API-DMAC10.html)
AU1581370A (cg-RX-API-DMAC10.html)
AU2119370A (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
PL Patent ceased